← All stocks

GALECTIN THERAPEUTICS INC

GALT Net selling
CIK 0001133416 #3361 in the set updated 17 Sep 2026
Bought (12 mo)
$25.55K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$6.07M
$595.80K on a plan · $3.96M straight out of an exercise
Sold at will
$1.51M
6 of 67 sales
Net
−$6.04M
−$1.49M against sales at will

By person

10 insiders · 73 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Shlevin Harold H.
Director
$1.56M (14) scheduled
−$1.56M
26,123
$133.89K
−7.1%
10X Fund, L.P. entity
10% owner
$1.51M (6)
−$1.51M
5,614,457
$28.78M
−5.0%
Jamil Khurram
Chief Medical Officer
$1.44M (17) scheduled
−$1.44M
0
$0.00
CALLICUTT JACK W
Chief Financial Officer
$944.40K (20) scheduled
−$944.40K
7,614
$39.02K
0.0%
LEWIS JOEL
President and CEO
$620.54K (10) scheduled
−$620.54K
832,592
$4.27M
−6.3%
FREEMAN KEVIN D
Director
$19.51K (1)
+$19.51K
135,269
$693.28K
+30.7%
ELDRED KARY
Director
$6.03K (3)
+$6.03K
65,682
$336.63K
+34.0%
Uihlein Richard E
Director
55,046,519
$282.12M
+166.9%
CZIRR JAMES C
10% owner
1,045,541
$5.36M
+41.0%
Zordani Richard A. Jr.
Director
42,083
$215.68K
+31.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Jamil Khurram
14 Jul 2026
Chief Medical Officer
Sold after exercise
16,250
$5.13
$83.28K
Jamil Khurram
29 Jun 2026
Chief Medical Officer
Sold after exercise
47,467
$5.04
$239.23K
Shlevin Harold H.
29 Jun 2026
Director
Sold after exercise
22,268
$5.04
$112.23K
Jamil Khurram
26 Jun 2026
Chief Medical Officer
Sold after exercise
2,533
$5.00
$12.67K
Jamil Khurram
26 Jun 2026
Chief Medical Officer
Sold after exercise
2,037
$5.00
$10.19K
Shlevin Harold H.
26 Jun 2026
Director
Sold after exercise
7,732
$5.00
$38.66K
Jamil Khurram
23 Jun 2026
Chief Medical Officer
Sold after exercise
7,557
$3.14
$23.73K
Jamil Khurram
26 May 2026
Chief Medical Officer
Sold after exercise
568
$3.10
$1.76K
Jamil Khurram
2 Jan 2026
Chief Medical Officer
Sold after exercise
13,055
$4.20
$54.79K
CALLICUTT JACK W
2 Jan 2026
Chief Financial Officer
Sold after exercise
13,914
$4.20
$58.39K
LEWIS JOEL
2 Jan 2026
President and CEO
Sold after exercise
18,571
$4.20
$77.94K
Jamil Khurram
31 Dec 2025
Chief Medical Officer
Sold after exercise
8,125
$4.07
$33.09K
Shlevin Harold H.
17 Dec 2025
Director
Sold after exercise
4,706
$7.04
$33.12K
Shlevin Harold H.
17 Dec 2025
Director
Sold after exercise
19,793
$7.04
$139.30K
Jamil Khurram
17 Dec 2025
Chief Medical Officer
Sold after exercise
8,500
$7.04
$59.84K
Jamil Khurram
17 Dec 2025
Chief Medical Officer
Sold after exercise
6,463
$7.04
$45.50K
Jamil Khurram
17 Dec 2025
Chief Medical Officer
Sold after exercise
4,479
$7.04
$31.53K
LEWIS JOEL
17 Dec 2025
President and CEO
Sold after exercise
7,829
$7.06
$55.24K
Shlevin Harold H.
15 Dec 2025
Director
Sold after exercise
8,417
$6.30
$53.03K
Shlevin Harold H.
12 Dec 2025
Director
Sold after exercise
19,793
$6.27
$124.18K
Shlevin Harold H.
9 Dec 2025
Director
Sold after exercise
16,790
$6.27
$105.21K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
20,000
$6.00
$120.04K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
35,000
$6.02
$210.67K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
25,000
$5.95
$148.65K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
20,000
$5.96
$119.24K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
20,000
$5.96
$119.24K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
35,000
$5.95
$208.25K
Shlevin Harold H.
8 Dec 2025
Director
Sold after exercise
4,000
$6.01
$24.02K
CALLICUTT JACK W
18 Nov 2025
Chief Financial Officer
Sold after exercise
18,210
$6.22
$113.32K
CALLICUTT JACK W
18 Nov 2025
Chief Financial Officer
Sold after exercise
28,100
$6.22
$174.87K
LEWIS JOEL
18 Nov 2025
President and CEO
Sold after exercise
6,783
$6.15
$41.72K
CALLICUTT JACK W
17 Nov 2025
Chief Financial Officer
Sold after exercise
2,323
$6.03
$14.01K
CALLICUTT JACK W
17 Nov 2025
Chief Financial Officer
Sold after exercise
19,701
$6.03
$118.83K
CALLICUTT JACK W
17 Nov 2025
Chief Financial Officer
Sold after exercise
9,586
$6.03
$57.82K
LEWIS JOEL
17 Nov 2025
President and CEO
Sold after exercise
15,680
$6.04
$94.64K
Jamil Khurram
13 Nov 2025
Chief Medical Officer
Sold after exercise
16,250
$5.47
$88.89K
Jamil Khurram
13 Nov 2025
Chief Medical Officer
Sold after exercise
41,500
$5.47
$227.01K
Jamil Khurram
13 Nov 2025
Chief Medical Officer
Sold after exercise
41,500
$5.47
$227.01K
Jamil Khurram
13 Nov 2025
Chief Medical Officer
Sold after exercise
21,867
$5.47
$119.61K
CALLICUTT JACK W
10 Nov 2025
Chief Financial Officer
Sold after exercise
1,736
$6.03
$10.47K
CALLICUTT JACK W
10 Nov 2025
Chief Financial Officer
Sold after exercise
1,675
$6.03
$10.09K
CALLICUTT JACK W
10 Nov 2025
Chief Financial Officer
Sold after exercise
1,880
$6.02
$11.32K
LEWIS JOEL
10 Nov 2025
President and CEO
Sold after exercise
1,867
$6.03
$11.25K
CALLICUTT JACK W
5 Nov 2025
Chief Financial Officer
Sold after exercise
200
$6.00
$1.20K
CALLICUTT JACK W
5 Nov 2025
Chief Financial Officer
Sold after exercise
200
$6.00
$1.20K
CALLICUTT JACK W
5 Nov 2025
Chief Financial Officer
Sold after exercise
200
$6.00
$1.20K
LEWIS JOEL
5 Nov 2025
President and CEO
Sold after exercise
200
$6.00
$1.20K
CALLICUTT JACK W
4 Nov 2025
Chief Financial Officer
Sold after exercise
10,741
$6.07
$65.20K
CALLICUTT JACK W
4 Nov 2025
Chief Financial Officer
Sold after exercise
8,974
$6.07
$54.47K
CALLICUTT JACK W
4 Nov 2025
Chief Financial Officer
Sold after exercise
8,914
$6.07
$54.11K
LEWIS JOEL
4 Nov 2025
President and CEO
Sold after exercise
14,420
$6.07
$87.53K
CALLICUTT JACK W
3 Nov 2025
Chief Financial Officer
Sold after exercise
1,250
$6.01
$7.51K
CALLICUTT JACK W
3 Nov 2025
Chief Financial Officer
Sold after exercise
1,260
$6.01
$7.57K
CALLICUTT JACK W
3 Nov 2025
Chief Financial Officer
Sold after exercise
1,300
$6.01
$7.81K
LEWIS JOEL
3 Nov 2025
President and CEO
Sold after exercise
1,300
$6.01
$7.81K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 55
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 35,230,404
History held since 24 Oct 2016